Keto Gummies Website All You Need To Know About Keto Gummies
Constipation And Keto How To Not Get Constipated On A Ketogenic Diet
FREE trial here http://www.lnk123.com/SHcGA
From the Dr. Oz Show
Lose Weight with Green Coffee Bean ( Dr. Oz Review )
One Shot Keto Scam Review The Fake Oneshot Keto Diet Pills
This yoga exercise will be help to lose weight and reduce belly fat easily if practiced on regular basis.
Keto Diet And Insulin Resistance Is It The Best Diet
Calorie Burn Calculator: https://physiosunit.com/calorie-to-burn-calculator-walking-running/
अगर आप वजन घटाना चाहते हैं, तो यह वीडियो आपके लिए है! जानें कैसे कैलोरी बर्न कैलकुलेटर आपकी मदद कर सकता है अपने दैनिक कैलोरी बर्न को ट्रैक करने में और वजन घटाने के लक्ष्य को प्राप्त करने में।
Watch full video: https://www.youtube.com/watch?v=4_5n64Rc3PA
Year Sponsored By Cottage Cheese And Hard Boiled Eggs Weightloss Weightlosstransformation
Did you know GLP1 meds could bankrupt healthcare? The shocking truth about why some patients can't get coverage!
The financial strain of GLP1 medications is forcing difficult decisions in healthcare. Julie Schulz and Mike Dovidio discuss how the expanding indications could qualify over half the US population, creating unsustainable costs for insurers.
Discover how Avalon Healthcare Systems is using data to create more personalized, equitable healthcare solutions while managing costs. Learn about the challenges of GLP1 medications and how innovative approaches to patient selection can improve outcomes while reducing administrative burdens.
Don't forget to like, subscribe, and hit the notification bell to stay updated on more inspiring stories of innovation and resilience!
____
1 The Universal Challenge: Saving Money in a Strapped Economy (m.j)
[00:00:00] nathan-c-_2_01-17-2025_092011: What are the kinds of questions that they're bringing to you? how do these conversations, these partnerships get started?
[00:00:06] Mike Dovidio: Typically it starts with how can you save us money?
Everybody's strapped right now. You see it across basically every industry. but when we think about specifically like GLP1s, we're already seeing that the sort of pot of dollars that a health insurer has to work with is not enough to cover all of the patients that A, are eligible for the drug based on the FDA approval, but b, want the drug.
You know, there's a lot more patients out there that want the drug that may not have diabetes. you know, even I would go as far as, say, aren't, obese by definition of what your BMI is. And so we are already starting to see some of these health plans quite literally have to lay off their workforce because they've just gone above and beyond what their budget is for their pharmacy spend.
and specifically [00:01:00] noting that GLP1s are a big source of, you know, what's sort of.
pulling those dollars away
[00:01:11] nathan-c-_2_01-17-2025_092011: So if I heard correctly. In the industry, the cost of supporting GLP1's for even just the folks who deserve it or who qualify for it medically, and if you include the rest of the folks who want it, is straining that care budget to the point where insurers have to lay people off in order to fulfill those insurance obligations.
[00:01:40] julie-schulz_1_01-17-2025_092011: Exactly. And I would add if it's okay, you know, patients are suffering as a result of this too, because if you look at, North Carolina, for example, they initially offered coverage for, weight loss for GLP1's, but spent a hundred million dollars on it, went completely over budget, and now we're in a situation where they can't cover it at all. and [00:02:00] so we really need to help find that. sort of happy medium of, where we can provide coverage to the patients who need it most in a cost effective manner.
but unfortunately, if we let everyone who qualifies for GLP1's, which, given the expanding set of indications, could be more than half of the US population, we would completely, bust the budget of our health care programs.
00:00 1 - The Universal Challenge: Saving Money in a Strapped Economy
Al Roker Slams People Judging Kelly Clarkson For Weightloss Drug Confession Back Off
On the latest “Pet Pals TV,” host Patty Spitler was joined by Tom Dock, the communications manager for Noah’s Animal Hospitals, to talk about the dangers that weight loss dogs have on pets.
https://www.wishtv.com/pet-pals-tv/pet-pals-tv-dangers-of-weight-loss-drugs/
---------------------------------------------------
WISH-TV website | https://www.wishtv.com
Follow us!
https://www.facebook.com/WISHNews8
https://www.instagram.com/WISH8News/
https://www.tiktok.com/@WISHNews8
https://twitter.com/WISHNews8
https://www.threads.net/@wish8news
Download the WISH-TV App | https://bit.ly/3vMkd5q
Subscribe to the WISH-TV Newsletter | https://www.wishtv.com/email-alerts/
Have a news tip? Email us at [email protected]
My Weight Loss Journey Day 26 Weightlossjourney Weightlosediary Minivlog Weightlosstips Food
Understanding how medications work is crucial in comprehending their effects on our bodies. Semaglutide, a relatively new drug on the market, has gained attention for its potential in aiding weight loss. In this article, we will delve into the mechanisms behind how semaglutide works to promote weight loss.
The Science Behind Semaglutide
Semaglutide belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists. GLP-1 is a hormone that is naturally produced in the gut in response to food intake. It plays a crucial role in regulating blood sugar levels by stimulating insulin release and reducing glucagon secretion. In addition to its effects on blood sugar, GLP-1 also helps suppress appetite and slows down gastric emptying, leading to a feeling of fullness.
When semaglutide is administered, it mimics the actions of GLP-1 in the body. By binding to the GLP-1 receptors on pancreatic beta cells, it stimulates insulin secretion in response to elevated blood sugar levels. This helps improve glucose control in individuals with type 2 diabetes. Furthermore, semaglutide also acts on the hypothalamus in the brain, which is responsible for regulating appetite and energy balance. By activating GLP-1 receptors in the brain, semaglutide helps reduce food intake and promote weight loss.
In addition to its effects on appetite regulation, semaglutide also has metabolic benefits that contribute to weight loss. Studies have shown that semaglutide can increase energy expenditure, or the number of calories burned at rest. This is important for weight loss as it helps create a calorie deficit, where the body uses more calories than it consumes. Semaglutide also promotes the utilization of stored fat for fuel, leading to further weight loss.
Potential Side Effects of Semaglutide
While semaglutide has shown promising results in promoting weight loss, it is not without potential side effects. Like other GLP-1 receptor agonists, semaglutide may cause gastrointestinal symptoms such as nausea, vomiting, and diarrhea. These side effects are usually mild to moderate in severity and tend to improve over time as the body adjusts to the medication.
In rare cases, semaglutide may also increase the risk of pancreatitis, a condition characterized by inflammation of the pancreas. Symptoms of pancreatitis include severe abdominal pain, nausea, and vomiting. It is important to seek medical attention immediately if you experience these symptoms while taking semaglutide. Additionally, there have been reports of an increased risk of thyroid tumors in animal studies with semaglutide, although the relevance of these findings to humans is still unclear.
Another potential side effect of semaglutide is hypoglycemia, or low blood sugar. This can occur if the dose of semaglutide is too high or if it is taken in combination with other medications that lower blood sugar. Symptoms of hypoglycemia include dizziness, sweating, confusion, and in severe cases, loss of consciousness. It is important to monitor blood sugar levels closely while taking semaglutide to prevent hypoglycemia.
Conclusion
In conclusion, semaglutide is a promising medication for weight loss that works by mimicking the actions of the hormone GLP-1. By reducing appetite, increasing energy expenditure, and promoting the utilization of stored fat, semaglutide helps individuals achieve and maintain weight loss. However, it is important to be aware of the potential side effects of semaglutide and to discuss any concerns with a healthcare provider. With further research and clinical trials, semaglutide may become a valuable tool in the management of obesity and related health conditions.
